Internal Medicine, Medical Oncology · Atlanta, GA
NPI
1558479188
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1365 Clifton Rd NE
Atlanta, GA, 30322
Phone (404) 778-1900
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
323 services
Medicare patients, 2024
158
Average age 72
Drug cost, 2024
$3.2M
797 prescriptions
Company payments, 2025
$92K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nabil F Saba was code 99215 (office e&m - established), 208 times for 105 patients. In total Nabil F Saba billed 323 services in 13 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-11-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 208 | 105 | $107.23 | $22K |
| 99205 Office E&M - New | Facility | 59 | 59 | $138.22 | $8,155 |
| 99214 Office E&M - Established | Facility | 18 | 13 | $60.82 | $1,095 |
By year: 2022 $41K for 368 services; 2023 $33K for 297 services; 2024 $35K for 323 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nabil F Saba prescribed most often to Medicare patients was Ondansetron Hcl, with 101 prescriptions and refills. In total Nabil F Saba wrote 797 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Hcl Generic | 101 | 101 | 60 | $1,755 |
| Prochlorperazine Maleate Generic | 83 | 83 | 45 | $644 |
| Dexamethasone Generic | 80 | 80 | 35 | $595 |
| Mekinist Trametinib Dimethyl Sulfoxide | 51 | 51 | Under 11 | $853K |
| Tafinlar Dabrafenib Mesylate | 51 | 51 | Under 11 | $709K |
| Lenvima Lenvatinib Mesylate | 28 | 28 | Under 11 | $666K |
| Levothyroxine Sodium Generic | 23 | 24 | Under 11 | $79.65 |
| Cabometyx Cabozantinib S-Malate | 23 | 23 | Under 11 | $576K |
| Prednisone Generic | 21 | 23 | 11 | $77.21 |
| Lidocaine Hcl Viscous Lidocaine Hcl | 20 | 20 | Under 11 | $306 |
| Verzenio Abemaciclib | 19 | 19 | Under 11 | $168K |
| Ondansetron Odt Ondansetron | 16 | 16 | Under 11 | $149 |
| Oxycodone Hcl Generic | 16 | 16 | 14 | $125 |
| Naloxone Hcl Generic | 16 | 16 | 16 | $1,128 |
| Clindamycin Phosphate Generic | 14 | 14 | Under 11 | $303 |
Brand drugs: 226 claims; generic drugs: 571 claims; opioid claims: 58.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nabil F Saba $92K ($89K in general payments such as food, travel and fees and $3,461 for research) from 21 companies. The largest payer was Dr.Reddy's Laboratories,Inc. with $29K.
| Company | Payments | Amount |
|---|---|---|
| Dr.Reddy's Laboratories,Inc. RDY | 8 | $29K |
| Exelixis Inc. EXEL | 15 | $26K |
| Merck Sharp & Dohme LLC MRK | 11 | $11K |
| GlaxoSmithKline, LLC. GSK | 5 | $3,406 |
| Janssen Scientific Affairs, LLC JNJ | 2 | $3,173 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $2,766 |
| Coherus Oncology, Inc. CHRS | 2 | $2,388 |
| Precigen, Inc. PGEN | 1 | $2,250 |
| Janssen Global Services, LLC JNJ | 4 | $2,248 |
| Janssen Research & Development, LLC JNJ | 1 | $2,115 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.